Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
Clinical trial NCT01419184 · COMPLETED
Trial details
- NCT number
- NCT01419184
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-09
- Primary completion
- 2012-09-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.